The aim of this study was to compare patients' salivary cortisol levels with AD severity and other associated stress-related psychological measures/parameters.
Methods
This prospective study analyzed salivary cortisol levels (enzyme-linked immunosorbent assay) in 84 AD patients (42 symptomatic patients and 42 asymptomatic patients). Each subject filled out the Perceived Stress Scale (PSS), Brief Illness Perception Questionnaire, and the Crown-Crisp Experiential Index, which concerns personality features.
Results
Increased cortisol values were found in both groups and were not dependent on disease severity (Scoring Atopic Dermatitis [SCORAD]) and PSS. Patients with severe AD had significantly lower cortisol levels than those with moderate and mild AD (P = 0.042). The PSS levels were not dependent on SCORAD but correlated with the perceived effect of AD on emotional states (Illness Perception Questionnaire 8), personality traits, anxiety, and depression (P < 0.001).
Conclusions
The severity of perceived stress in AD patients is not adequately measured by salivary cortisol levels nor SCORAD; it does, however, correlate with the impact of AD on patients' emotional states and personality features (anxiety, depression). All AD patients, regardless of disease severity, should be assessed for impacts of stress, and a multidisciplinary approach should address mental wellness.
Get full access to this article
View all access options for this article.
References
1.
SilverbergJI, GelfandJM, MargolisDJ, et al. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults. Br J Dermatol, 2019; 181(3):554–565.
2.
WittkowskiA, RichardsHL, GriffithsCE, et al.Illness perception in individuals with atopic dermatitis. Psychol Health Med, 2007; 12(4):433–444.
SchonmannY, MansfieldKE, HayesJF, et al.Atopic eczema in adulthood and risk of depression and anxiety: a population-based cohort study. J Allergy Clin Immunol Pract, 2020; 8(1):248–257.e16.
6.
MizawaM, YamaguchiM, UedaC, et al.Stress evaluation in adult patients with atopic dermatitis using salivary cortisol. Biomed Res Int, 2013; 2013:138027. doi:.
7.
Meštrović-ŠtefekovJ, Novak-BilićG, KunaM, et al.Psychological stress in patients with atopic dermatitis. Acta Dermatovenerol Croat, 2018; 26(4):297–303.
8.
ChoiGS, NamYH, ParkCS, et al.Anxiety, depression, and stress in Korean patients with chronic urticaria. Korean J Intern Med, 2020; 35(6):1507–1516.
9.
KarlovićD, SerrettiA, VrkićN, et al.Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Res, 2012; 198(1):74–80.
10.
PasqualucciPL, DamasoLLM, DanilaAH, et al.Prevalence and correlates of depression, anxiety, and stress in medical residents of a Brazilian academic health system. BMC Med Educ, 2019; 19(1):193.
11.
SlominskiA.A nervous breakdown in the skin: stress and the epidermal barrier. J Clin Invest, 2007; 117(11):3166–3169.
12.
Lugović-MihićL, LjubešićL, MihićJ, et al.Psychoneuroimmunologic aspects of skin diseases. Acta Clin Croat, 2013; 52(3):337–345.
13.
InderWJ, DimeskiG, RussellA. Measurement of salivary cortisol in 2012—laboratory techniques and clinical indications. Clin Endocrinol, 2012; 77(5):645–651.
14.
HellhammerDH, WüstS, KudielkaBM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology, 2009; 34(2):163–171.
15.
BožovićD, RačićM, IvkovićN. Salivary cortisol levels as a biological marker of stress reaction. Mediev Archaeol, 2013; 67(5):374–377.
16.
BlairJ, AdawayJ, KeevilB, et al.Salivary cortisol and cortisone in the clinical setting. Curr Opin Endocrinol Diabetes Obes, 2017; 24(3):161–168.
17.
LevineA, Zagoory-SharonO, FeldmanR, et al.Measuring cortisol in human psychobiological studies. Physiol Behav, 2007; 90(1):43–53.
18.
KirschbaumC, HellhammerDH. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology, 1994; 19(4):313–333.
19.
GoodyerIM, ParkRJ, NethertonCM, et al.Possible role of cortisol and dehydroepiandrosterone in human development and psychopathology. Br J Psychiatry, 2001; 179:243–249.
20.
DebonoM, GhobadiC, Rostami-HodjeganA, et al.Modified-release hydrocortisone to provide circadian cortisol profiles. Clin Endocrinol Metab, 2009; 94(5):1548–1554.
21.
GozanskyWS, LynnJS, LaudenslagerML, et al.Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic-pituitary-adrenal axis activity. Clin Endocrinol, 2005; 63(3):336–341.
22.
JungC, GrecoS, NguyenHH, et al.Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers. BMC Endocr Disord, 2014; 14:91.
23.
Šupe-DomićD, MilasG, HofmanID, et al.Daily salivary cortisol profile: insights from the Croatian Late Adolescence Stress Study (CLASS). Biochem Med (Zagreb), 2016; 26(3):408–420.
24.
CrnkovićD, PecoM, GeloJ. Correlation between salivary biochemical stress indicators and psychological indicators. Acta Clin Croat, 2018; 57(2):316–326.
25.
AshH, SmithTE, KnightS, et al.Measuring physiological stress in the common marmoset (Callithrix jacchus): validation of a salivary cortisol collection and assay technique. Physiol Behav, 2018; 185:14–22.
26.
HanifinJM, RajkaG. Diagnositic features of atopic dermatitis. Acta Derm Venereol, 1980; 92:44–47.
27.
KunzB, OranjeAP, LabrèzeL, et al.Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology, 1997; 195(1):10–19.
28.
Cortisol Saliva Test Instruction (written on the attached paper prepared for ELISA for salivary cortisol measurement, supplied by the manufacturer).
29.
CohenS, KamarckT, MermelsteinR. A global measure of perceived stress. J Health Soc Behav, 1983; 24(4):385–396.
30.
BirtchnellJ, EvansC, KennardJ. The total score of the Crown-Crisp experiential Index: a useful and valid measure of psychoneurotic pathology. Br J Med Psychol, 1988; 61(Pt 3):255–266.
CohenJ.A power primer. Psychol Bull, 1992; 112:155–159.
33.
RosenthalJA.Qualitative descriptors of strength of association and effect size. J Soc Serv Res, 1996; 21:37–59.
34.
BieberT.Atopic dermatitis. Ann Dermatol, 2010; 22(2):125–137.
35.
BieberT.Atopic dermatitis. N Engl J Med, 2008; 358(14):1483–1494.
36.
Buske-KirschbaumA, GierensA, HölligH, et al.Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol, 2002; 129(1–2):161–167.
37.
DalgardFJ, BewleyA, EversAW, et al.Stigmatisation and body image impairment in dermatological patients: protocol for an observational multicentre study in 16 European countries. BMJ Open, 2018; 8(12):e024877. doi:.
SuárezAL, FeramiscoJD, KooJ, et al.Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates. Acta Derm Venereol, 2012; 92(1):7–15.
40.
TangYY, MaY, FanY, et al.Central and autonomic nervous system interaction is altered by short-term meditation. Proc Natl Acad Sci U S A, 2009; 106(22):8865–8870.
41.
SchmittJ, Buske-KirschbaumA, RoessnerV. Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review. Allergy, 2010; 65(12):1506–1524.
42.
YaghmaieP, KoudelkaCW, SimpsonEL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol, 2013; 131(2):428–433.
43.
ArzaA, Garzón-ReyJM, LázaroJ, et al.Measuring acute stress response through physiological signals: towards a quantitative assessment of stress. Med Biol Eng Comput, 2019; 57(1):271–287.
44.
GoyalA, SinghS, VirD, et al.Automation of stress recognition using subjective or objective measures. Psychol Stud, 2016; 61(4):348–364.
45.
RaiB, KaurJ, AnandSC, et al.Salivary stress markers, stress, and periodontitis: a pilot study. J Periodontol, 2011; 82(2):287–292.
46.
HaeckIM, Timmer-de MikL, LentjesEG, et al.Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused. Br J Dermatol, 2007; 156(5):979–985.
47.
FukudaH, SuzukiT, SaotomeA, et al.Efficacy of inpatient treatment for atopic dermatitis evaluated by changes in serum cortisol levels. J Dermatol, 2013; 40(1):43–47.
48.
KudielkaBM, HellhammerDH, WüstS. Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology, 2009; 34(1):2–18.
49.
HammerfaldK, EberleC, GrauM, et al.Persistent effects of cognitive-behavioral stress management on cortisol responses to acute stress in healthy subjects—a randomized controlled trial. Psychoneuroendocrinology, 2006; 31(3):333–339.
50.
WamboldtMZ, LaudenslagerM, WamboldtFS, et al.Adolescents with atopic disorders have an attenuated cortisol response to laboratory stress. J Allergy Clin Immunol, 2003; 111(3):509–514.
51.
EschenbeckH, KohlmannCW, LohausA. Gender differences in coping strategies in children and adolescents. Am Psychol, 2007; 28(1):18–26.
52.
LifschitzC.The impact of atopic dermatitis on quality of life. Ann Nutr Metab, 2015; 66(suppl 1):34–40.
53.
StephensMA, WandG. Stress and the HPA axis: role of glucocorticoids in alcohol dependence. Alcohol Res, 2012; 34(4):468–483.
54.
PondeljakN, Lugović-MihićL. Stress-induced interaction of skin immune cells, hormones, and neurotransmitters. Clin Ther, 2020; 42(5):757–770.
55.
Buske-KirschbaumA, von AuerK, KriegerS, et al.Blunted cortisol responses to psychosocial stress in asthmatic children: a general feature of atopic disease?. Psychosom Med, 2003; 65(5):806–810.
